[
    [
        {
            "time": "",
            "original_text": "继投下4个“恒瑞”，大半个“上海医药”后，高瓴又来钱了！1160亿又会买谁？大药企、CRO、投资机构争夺战要开始了？",
            "features": {
                "keywords": [
                    "高瓴",
                    "恒瑞",
                    "上海医药",
                    "CRO",
                    "投资机构"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "继投下4个“恒瑞”，大半个“上海医药”后，高瓴又来钱了！1160亿又会买谁？大药企、CRO、投资机构争夺战要开始了？",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "下周57.46亿股限售股解禁，解禁市值达1723.38亿元，药明康德解禁市值超900亿（附名单） 解禁",
            "features": {
                "keywords": [
                    "解禁",
                    "药明康德",
                    "限售股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "下周57.46亿股限售股解禁，解禁市值达1723.38亿元，药明康德解禁市值超900亿（附名单） 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "下周1700亿解禁洪流来袭 医药龙头股超900亿市值将解禁 解禁",
            "features": {
                "keywords": [
                    "解禁",
                    "医药",
                    "龙头股"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "下周1700亿解禁洪流来袭 医药龙头股超900亿市值将解禁 解禁",
                "Correlation": 8,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "医药大牛股超900亿解禁来袭 22位股东三年大赚近13倍",
            "features": {
                "keywords": [
                    "解禁",
                    "医药",
                    "股东"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药大牛股超900亿解禁来袭 22位股东三年大赚近13倍",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "[加急]下周解禁总量约41.6亿股，药明康德解禁市值达907亿元 解禁",
            "features": {
                "keywords": [
                    "解禁",
                    "药明康德",
                    "市值"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "[加急]下周解禁总量约41.6亿股，药明康德解禁市值达907亿元 解禁",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 10,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 10,
                "Headline_Structure": 10,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "下周解禁市值超1700亿，药明康德解禁超900亿元 解禁",
            "features": {
                "keywords": [
                    "解禁",
                    "药明康德",
                    "市值"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "下周解禁市值超1700亿，药明康德解禁超900亿元 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "解禁潮来袭！下周解禁市值超1700亿，药明康德解禁超900亿元！这些股票解禁压力大（附名单） 解禁",
            "features": {
                "keywords": [
                    "解禁",
                    "药明康德",
                    "压力"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "解禁潮来袭！下周解禁市值超1700亿，药明康德解禁超900亿元！这些股票解禁压力大（附名单） 解禁",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "易会满重磅发声，提高直接融资比重！1700亿解禁洪流来袭，医药龙头股超900亿市值将解禁，超8成解禁股业绩亮眼 解禁",
            "features": {
                "keywords": [
                    "解禁",
                    "医药",
                    "龙头股",
                    "直接融资",
                    "业绩"
                ],
                "sentiment_score": -0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "金融"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "易会满重磅发声，提高直接融资比重！1700亿解禁洪流来袭，医药龙头股超900亿市值将解禁，超8成解禁股业绩亮眼 解禁",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]